Rakovina to Present at the 2022 Annual Meeting of the American Association of Cancer Research (AACR)
Rakovina Therapeutics presentation will highlight pre-clinical research related to its novel kt-4000 series.
top of page
- Apr 21, 2023
- 3 min
Rakovina Therapeutics Announces Non-dilutive Financial Contributions....
Funding will support the development of new research infrastructure for screening and optimization of potential drug candidates...
- Apr 21, 2023
- 3 min
Rakovina Therapeutics Inc. Receives Notice of Allowance for New U.S. Patent Covering kt-2000 series
The granted patent claims cover the composition of matter and uses of drug candidates from Rakovina Therapeutics’ kt-2000 series...
- Apr 21, 2023
- 3 min
Rakovina Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update
Rakovina is pleased to report steady progress in research activities as they establish Rakovina as a publicly listed company...
1/17
Galantas Gold Corp. - Exploring and Mining Irish Gold
Play Video
Rakovina Therapeutics Inc. - Revolutionizing Cancer Treatments to Improve Patient Outcomes
Play Video
Golden Goliath Resources - Rare Earth Element Discoveries in Quebec
Play Video
Alpha Cognition Inc. - A New Dawn in Alzheimer's Care
Play Video
Visionstate Corp. - IoT, AI, Big Data - Turning Ideas Into Transformation
Play Video
AI/ML Innovations Inc. - Fusing AI and Machine Learning to Innovate Health Care Management
Play Video
Boron One Holdings Inc. - Pioneering the Next World-Class Boron Asset in the Heart of Europe
Play Video
Klimat X Developments Inc. - Carbon Credit Project Development
Play Video
Play Video
Play Video
Share
Facebook
Twitter
Pinterest
Tumblr
Copy Link
Link Copied
© 2023 Frontier Merchant Capital Group. All Rights Reserved.
bottom of page